Anhui Anke Biotechnology (Group) Co., Ltd. (SHE: 300009)
China flag China · Delayed Price · Currency is CNY
9.22
-0.13 (-1.39%)
Nov 15, 2024, 3:04 PM CST

Anhui Anke Biotechnology (Group) Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Jan '23 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
15,41717,09415,62321,44820,04415,849
Upgrade
Market Cap Growth
-1.02%9.42%-27.16%7.00%26.47%18.95%
Upgrade
Enterprise Value
14,39816,08914,82220,62719,44515,561
Upgrade
Last Close Price
9.229.968.9012.1811.278.85
Upgrade
PE Ratio
19.6319.5320.6993.7051.24117.95
Upgrade
PS Ratio
5.565.976.709.8911.789.25
Upgrade
PB Ratio
4.044.354.597.396.845.87
Upgrade
P/FCF Ratio
25.8822.5669.5546.5361.43145.21
Upgrade
P/OCF Ratio
21.9717.9422.3536.2243.1253.61
Upgrade
EV/Sales Ratio
5.215.616.369.5111.439.09
Upgrade
EV/EBITDA Ratio
15.5115.9917.7330.4842.0333.69
Upgrade
EV/EBIT Ratio
17.6117.6219.6134.4249.0238.95
Upgrade
EV/FCF Ratio
24.1721.2465.9844.7559.60142.56
Upgrade
Debt / Equity Ratio
0.010.010.010.010.000.01
Upgrade
Debt / EBITDA Ratio
0.060.060.040.040.030.06
Upgrade
Debt / FCF Ratio
0.090.070.150.060.040.26
Upgrade
Asset Turnover
0.580.620.590.600.510.60
Upgrade
Inventory Turnover
2.282.832.622.592.613.44
Upgrade
Quick Ratio
2.662.432.452.743.103.21
Upgrade
Current Ratio
3.202.752.833.073.473.56
Upgrade
Return on Equity (ROE)
20.21%23.41%23.40%6.97%12.31%4.69%
Upgrade
Return on Assets (ROA)
10.67%12.39%11.92%10.44%7.37%8.68%
Upgrade
Return on Capital (ROIC)
12.86%15.37%14.84%12.75%8.74%10.32%
Upgrade
Earnings Yield
5.09%4.96%4.50%0.96%1.79%0.79%
Upgrade
FCF Yield
3.86%4.43%1.44%2.15%1.63%0.69%
Upgrade
Dividend Yield
2.67%2.51%2.81%1.64%1.48%1.09%
Upgrade
Payout Ratio
52.83%48.52%46.58%132.37%44.35%130.01%
Upgrade
Buyback Yield / Dilution
-0.64%-1.57%-2.90%2.58%1.68%-5.12%
Upgrade
Total Shareholder Return
2.04%0.94%-0.09%4.23%3.16%-4.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.